£84.29

Springer Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Price data last checked 94 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the usual price. Wait for it to drop, or tell us your number.

£84 today · usual range £0–£0 · best ever £77

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 637 days • 637 data points (No recent data available)

Historical
Generating forecast...
£84.55 £76.52 £78.27 £80.02 £81.78 £83.53 £85.28 10 June 2024 16 November 2024 24 April 2025 30 September 2025 08 March 2026

Price Distribution

Price distribution over 637 days • 6 price levels

Days at Price
Current Price
74 days 135 days 268 days 11 days 72 days 77 days · current 0 67 134 201 268 £77 £79 £80 £81 £82 £84 Days at Price

Price Analysis

Most common price: £80 (268 days, 42.1%)

Price range: £77 - £84

Price levels: 6 different prices over 637 days

Description

Multiple myeloma is currently still an incurable disease, but during the past decade knowledge of its molecular pathogenesis has increased rapidly. This has led to remarkable progress in both diagnosis and therapy, including in particular the approval of novel and first-in-class drugs such as thalidomide, bortezomib, and lenalidomide. This book, written by internationally acknowledged experts, covers a wide range of topics relating to multiple myeloma, including history, epidemiology, pathophysiology, clinical features, staging, and prognostic systems. The principal focus, however, is on therapy, with detailed information on the various promising treatment options which give hope that this cancer will be transformed into a chronic disease or even become curable. Individualized therapy and the variety of supportive treatment options, as described in this volume, will help in achieving this goal, as well as in reducing adverse events and improving quality of life. From the Back Cover Multiple myeloma is currently still an incurable disease, but during the past decade knowledge of its molecular pathogenesis has increased rapidly. This has led to remarkable progress in both diagnosis and therapy. In particular, the approval of novel and first-in-class drugs such as thalidomide, bortezomib, and lenalidomide means that multiple myeloma now stands at the forefront of advances in oncology drug development. This book, written by internationally acknowledged experts, covers a wide range of topics relating to multiple myeloma, including history, epidemiology, pathophysiology, clinical features, staging, and prognostic systems. The principal focus, however, is on therapy, with detailed information on the various promising treatment options which give hope that this cancer will be transformed into a chronic disease or even become curable. Individualized therapy and the variety of supportive treatment options, as described in this volume, will help in achieving this goal, as well as in reducing adverse events and improving quality of life.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)
98% match

Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)

Humana

£102.58 08 Jan 2026
Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
98% match

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Springer

£103.09 06 Jan 2026
Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)
98% match

Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)

Springer

£79.70 22 Feb 2026
Treatment of Multiple Myeloma and Related Disorders
98% match

Treatment of Multiple Myeloma and Related Disorders

Cambridge University Press

£36.41 27 Feb 2026
Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)
98% match

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Springer

£99.53 25 Feb 2026
Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside
98% match

Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside

Academic Press

£166.49 25 Jan 2026
Multiple Myeloma and Related Disorders (Hodder Arnold Publication)
97% match

Multiple Myeloma and Related Disorders (Hodder Arnold Publication)

CRC Press

£146.95 10 Jan 2026
Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)
97% match

Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)

Springer

£244.99 14 Jan 2026
Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)
97% match

Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)

£91.41 10 Mar 2026
Consulting Hematology and Oncology Handbook
97% match

Consulting Hematology and Oncology Handbook

Springer

£57.66 08 Mar 2026
Clinical Malignant Hematology
97% match

Clinical Malignant Hematology

McGraw-Hill Education

£103.37 14 Jan 2026
Multiple Myeloma: Methods and Protocols: 113 (Methods in Molecular Medicine, 113)
97% match

Multiple Myeloma: Methods and Protocols: 113 (Methods in Molecular Medicine, 113)

Humana

£31.08 07 Mar 2026
Springer Hematologic Cancers: Molecular Pathobiology to Therapy
97% match

Springer Hematologic Cancers: Molecular Pathobiology to Therapy

Springer

£113.48 20 Apr 2026
Myeloma Bone Disease (Current Clinical Oncology)
96% match

Myeloma Bone Disease (Current Clinical Oncology)

Humana

£139.86 21 Feb 2026
Horizons in Cancer Research. Volume 73: Volume 73
96% match

Horizons in Cancer Research. Volume 73: Volume 73

£116.24 11 Jan 2026
Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia
96% match

Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia

Springer

£92.42 08 Jan 2026
Oxford Textbook of Neurohaematology (Oxford Textbooks in Clinical Neurology)
96% match

Oxford Textbook of Neurohaematology (Oxford Textbooks in Clinical Neurology)

£141.08 24 Jan 2026
Hematologic Malignancies: Methods and Techniques: 55 (Methods in Molecular Medicine, 55)
96% match

Hematologic Malignancies: Methods and Techniques: 55 (Methods in Molecular Medicine, 55)

Humana

£72.56 17 Mar 2026
Contemporary Management of Multiple Myeloma
96% match

Contemporary Management of Multiple Myeloma

Jaypee Brothers Medical Publishers

£25.79 05 Mar 2026
Chronic Myeloid Leukemia: Methods and Protocols: 1465 (Methods in Molecular Biology)
96% match

Chronic Myeloid Leukemia: Methods and Protocols: 1465 (Methods in Molecular Biology)

Humana

£84.99 17 Mar 2026
Therapie der akuten Leukämien
96% match

Therapie der akuten Leukämien

Springer

£46.99 07 Mar 2026
Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)
96% match

Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)

Springer

£104.67 09 Mar 2026
Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)
96% match

Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)

Springer

£84.27 16 Feb 2026
Multiple Myeloma: Risk Factors, Diagnosis & Treatments (Cancer Etiology, Diagnosis and Treatments)
96% match

Multiple Myeloma: Risk Factors, Diagnosis & Treatments (Cancer Etiology, Diagnosis and Treatments)

£134.20 11 Jan 2026